Agile Cell Supply and Processing to Accelerate Development of the Medicines of the Future
MegaBulb DNA: a Non-Viral ssDNA Breakthrough Revolutionizing Gene Editing
Revolutionizing Autoimmune Disease Management with Soluble Bispecific Receptors
The Evolving Role of Remote Monitoring
Growing as a Trusted, Dedicated Commercial Biologics CDMO
Designing A Recipe for Stem Cell Therapy Success
Discussing the Advancements in Oncology
Preparing the Yacht for the Race
Disaster Strikes
Rethinking the Pharma/Biopharma Supply Chain to Maximize Resilience
Sailing into the Trade Winds
Building Multiple Platforms to Address Difficult-to-Treat Cancers
Assembling the Crew
The Power of Aqueous Detergents in Critical Cleaning
Transforming Market Insights into Growth
Transforming the Economics of AAV Manufacture While Optimizing Quality with dbDNA
Rethinking the Conventional CDMO Model
Mitigating Early Development Risks with Samsung Biologics DEVELOPICK™ Platform
Building on a Pioneering Biomanufacturing Legacy with Client Centricity
Assessing Developability and Designing Advanceable Formulations from the Start
Leveraging Risk Assessment for Demonstrating Product Comparability after Manufacturing Process Changes
Pharma’s Almanac’s weekly newsletter, featuring industry news and must-read original content on a range of topics.
Why Life Science Companies Surged amid a Global M&A Downturn
Innovating and Collaborating to Support Biopharma Beyond the Typical CDMO
Plan Ahead: Mastering Your AI Budget for 2025 Success
Optimized Residual dsRNA Detection for mRNA Therapeutics
Developing a Toolbox of Functional Bioassays for Optimizing ADCC
Agile Cell Supply and Processing to Accelerate Development of the Medicines of the Future
MegaBulb DNA: a Non-Viral ssDNA Breakthrough Revolutionizing Gene Editing
Revolutionizing Autoimmune Disease Management with Soluble Bispecific Receptors